Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

References

• YusufSHawkenSÖunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet200436493795215364185
   PubMed Web of Science ®Google Scholar
• SuperkoHRKingSIIILipid management to reduce cardiovascular risk: a new strategy is requiredCirculation200811756056818227396
   PubMed Web of Science ®Google Scholar
• AradYGoodmanKJRothMNewsteinDGuerciADCoronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart StudyJ Am Coll Cardiol20054615816515992651
   PubMed Web of Science ®Google Scholar
• AscasoJGonzález SantosPHernández MijaresAManagement of dyslipidemia in the metabolic syndrome. Recommendations of the Spanish HDL ForumAm J Cardiovasc Drugs20077395817355165
   PubMed Web of Science ®Google Scholar
• KinosianBGlickHGarlandGCholesterol and coronary heart disease: predicting risks by levels and ratiosAnn Intern Med19941216416477944071
   PubMed Web of Science ®Google Scholar
• GottoAMAssmannGCarmenaRThe ILIB lipid handbook for clinical practice: blood lipids and coronary heart disease2nd edNew York, NYInternational Lipid Information Bureau20005253201
   Google Scholar
• GenestJFrohlichJFodorGMcPhersonRthe Working Group on Hypercholesterolemia and Other DyslipidemiasRecommendations for the management of dyslipidemia and the prevention of cardiovascular disease: 2003 updateCMAJ200316992192414581310
   PubMed Web of Science ®Google Scholar
• PintóXRosELípidos séricos y predicción del riesgo cardiovascular: importancia de los cocientes colesterol total/colesterol HDL y colesterol LDL/colesterol HDLClin Invest Arterioscl200012267284
   Google Scholar
• ManninenVTenkanenLKoskinenPJoint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatmentCirculation19928537451728471
   PubMed Web of Science ®Google Scholar
• CriquiMHGolomBAEpidemiologic aspects of lipid abnormalitiesAm J Med1998105Suppl 1A48S57S9707268
   PubMedGoogle Scholar
• WalldiusGJungerIAastveitAHolmeIFurbergCDSnidermanADThe apoB-apoA-I ratio is better than the cholesterol ratios to estimate the balance between the plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskClin Chem Lab Med2004421355136315576296
   PubMed Web of Science ®Google Scholar
• SnidermanADJungerIHolmeIAastveitAWalldiusGErrors that result from using the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular diseaseJ Intern Med200625945546116629851
   PubMed Web of Science ®Google Scholar
• WalldiusGJungerIThe apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of evidenceJ Intern Med200625949351916629855
   PubMed Web of Science ®Google Scholar
• HolmeIAastveitAHJungerIWalldiusGRelationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)J Intern Med2008264303818298486
   PubMed Web of Science ®Google Scholar
• ThompsonADaneshJAssociations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studiesJ Intern Med200625948149216629854
   PubMed Web of Science ®Google Scholar
• DobiásováMFrohlichJThe plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL)Clin Biochem20013458358811738396
   PubMed Web of Science ®Google Scholar
• DobiásováMAtherogenic index of plasma [Log (triglycerides/HDL-cholesterol)]: theoretical and practical implicationsClin Chem2004501113111515229146
   PubMed Web of Science ®Google Scholar
• VegaGLBeltzWFGrundySMLow density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart diseaseJ Lipid Res1985261151263973508
   PubMed Web of Science ®Google Scholar
• FuruyaDYagihashiANasuSLDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratiosClin Chem2000461202120310926909
   PubMed Web of Science ®Google Scholar
• SnidermanADSt-PierreACCantinBDagenaisGRDespresJPLamarcheBConcordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic riskAm J Cardiol2003911173117712745098
   PubMed Web of Science ®Google Scholar
• RaderDJDavidsonMHCaplanRJPearsJSLipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatinAm J Cardiol200391Suppl20C24C
   PubMedGoogle Scholar
• CastelliWJGarrisonRJWilsonPWFAbbotRDKalousdianSKannelWBIncidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA1986256283528383773200
   PubMed Web of Science ®Google Scholar
• GroverSAPalmerCSCoupallLSerum lipid screening to identify high risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohortArch Intern Med19941546796848129502
   PubMedGoogle Scholar
• AssmannGSchulteHFunkeHvon EckardsteinASeedorfUMillerNEThe Prospective Cardiovascular Münster (PROCAM) StudyIdentification of high-risk individuals for myocardial infarction and the role of HDLHigh Density Lipoproteins and Atherosclerosis IIAmsterdam, The NetherlandsElsevier19895165
   Google Scholar
• AssmannGCullenPSchulteHThe Munster Heart Study (PROCAM). Results of follow-up at 8 yearsEur Heart J199819Suppl AA2A119519336
   PubMedGoogle Scholar
• The West of Scotland Coronary Prevention Study GroupBaseline risk factors and their association with outcome in the West of Scotland Coronary Prevention StudyAm J Cardiol1997797567629070554
   PubMed Web of Science ®Google Scholar
• GottoAWhitneyESteinEARelation between baseline and on-treatment lipid parameters and first acute major coronary event in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)Circulation200010147748410662743
   PubMed Web of Science ®Google Scholar
• PedersenTROlssonAGFaergemanOLipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)Circulation199897145314609576425
   PubMed Web of Science ®Google Scholar
• AndersonKMWilsonPWOdellPMKannelWBAn updated coronary risk profile. A statement for health professionalsCirculation1991833563621984895
   PubMed Web of Science ®Google Scholar
• HokansonJEAustinMAPlasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studiesJ Cardiovasc Risk199632132198836866
   PubMedGoogle Scholar
• StampferMJKraussRMMaJA prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA19962768828888782637
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHBuringJERifaiNC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med200034283684310733371
   PubMed Web of Science ®Google Scholar
• HongMKRommPAReaganKGreenCERackleyCEUsefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in womenAm J Cardiol199168164616501746467
   PubMed Web of Science ®Google Scholar
• NielsenNEOlssonAGSwahnEPlasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristicsJ Intern Med2000247435210672130
   PubMed Web of Science ®Google Scholar
• FrontiniMGSrinivasanSRXuJHTangRBondMGBerensonGUtility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study)Am J Cardiol2007100646817599442
   PubMed Web of Science ®Google Scholar
• SnidermanADFurbergCDKeechAApolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentLancet200336177778012620753
   PubMed Web of Science ®Google Scholar
• BarterPJBallantyneCMCarmenaRApo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelJ Intern Med200625924725816476102
   PubMed Web of Science ®Google Scholar
• IngelssonESchaeferEJContoisJHClinical utility of different lipid measures for prediction of coronary heart disease in men and womenJAMA200729877678517699011
   PubMed Web of Science ®Google Scholar
• van der SteegWABoekholdtSMSteinEARole of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-NorfolkAnn Intern Med200714664064817470832
   PubMed Web of Science ®Google Scholar
• JuonalaMViikariJSKähönenMChildhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the Cardiovascular Risk in Young Finns StudyJ Am Coll Cardiol20085229329918634985
   PubMed Web of Science ®Google Scholar
• ManninenVTenkanenLKoskinenPJoint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: implications for treatmentCirculation19928537461728471
   PubMed Web of Science ®Google Scholar
• BrensikeJELevyRIKelseySFEffects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention studyCirculation1984693133246360414
   PubMed Web of Science ®Google Scholar
• WattsGFLewisBBruntJNHEffects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerosis Regression Study (STARS)Lancet19923395635691347091
   PubMed Web of Science ®Google Scholar
• BrownBGFusterVFusterVRossRTopolEJImpact of management in stabilization of coronary diseaseAtherosclerosis and Coronary Artery DiseasePhiladelphia, PALippincott-Raven1996191205
   Google Scholar
• NicholsSjTuzcuEMSipahiIStatins, high-density lipoprotein cholesterol, and regression of coronary atheroscleorsisJAMA200729749950817284700
   PubMed Web of Science ®Google Scholar
• PintóXMecoJFCorbellaEPrograma de prevención secundaria de la arteriosclerosis de un hospital universitario. Resultados y factores predictivos del curso clínicoMed Clin (Barc)200312076877212797928
   PubMed Web of Science ®Google Scholar
• HsiaSHPanDBerookimPLeeMLA population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic diseaseAm J Cardiol2006981047105217027569
   PubMed Web of Science ®Google Scholar
• RidkerPMStampferMJRifaiNNovel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseJAMA20012852481248511368701
   PubMed Web of Science ®Google Scholar
• ShaiIRimmEBHankinsonSEMultivariate assessment of lipids parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelinesCirculation20041102824283015492318
   PubMed Web of Science ®Google Scholar
• NamBHKannelWBD’AgostinoRBSearch for an optimal atherogenic lipid risk profile: from the Framingham StudyAm J Cardiol20069737237516442398
   PubMed Web of Science ®Google Scholar
• Mounier-VehierCStephanDAboyansVGroupe vasculaire (SFC-Societe francaise de medecine vasculaires. The best of vascular medicine in 2006Arch Mal Coeur Vaiss2007100475517405565
   PubMedGoogle Scholar
• NatarajanSGlickHCriquiMHorowitzDLipsitzSRKinosianBCholesterol measures to identify and treat individuals at risk for coronary heart diseaseAm J Prev Med200325505712818310
   PubMed Web of Science ®Google Scholar